CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Common Stock Restricted Stock Units	Additional Paid-in Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive (Loss)/Income	Non-controlling interest in consolidated subsidiaries
Balance, beginning of period (in shares) at Dec. 31, 2021		56,849
Balance, beginning of period at Dec. 31, 2021	$ 2,495,837	$ 57		$ 711,912	$ 1,829,532	$ (177)	$ (54,207)	$ 8,720
Treasury stock, beginning of period (in shares) at Dec. 31, 2021						20
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)			193
Equity withheld for employee taxes (in shares)		(67)
Equity withheld for employee taxes	(18,376)			(18,376)
Stock-based compensation expense	22,702			22,702
Exercise of stock options (in shares)		158
Exercise of stock options	2,884			2,884
Purchase of subsidiary shares from noncontrolling interest	(7,067)							(7,067)
Other comprehensive income (loss)	(31,943)						(31,943)
Net income	89,719				89,719
Balance, end of period (in shares) at Mar. 31, 2022		57,133
Balance, end of period at Mar. 31, 2022	2,553,756	$ 57		719,122	1,919,251	$ (177)	(86,150)	1,653
Treasury stock, end of period (in shares) at Mar. 31, 2022						20
Balance, beginning of period (in shares) at Dec. 31, 2021		56,849
Balance, beginning of period at Dec. 31, 2021	2,495,837	$ 57		711,912	1,829,532	$ (177)	(54,207)	8,720
Treasury stock, beginning of period (in shares) at Dec. 31, 2021						20
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	(84,425)
Net income	264,377
Balance, end of period (in shares) at Sep. 30, 2022		57,502
Balance, end of period at Sep. 30, 2022	2,758,644	$ 57		801,950	2,093,909	$ (118)	(138,632)	1,478
Treasury stock, end of period (in shares) at Sep. 30, 2022						14
Balance, beginning of period (in shares) at Mar. 31, 2022		57,133
Balance, beginning of period at Mar. 31, 2022	2,553,756	$ 57		719,122	1,919,251	$ (177)	(86,150)	1,653
Treasury stock, beginning of period (in shares) at Mar. 31, 2022						20
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)			24
Equity withheld for employee taxes (in shares)		(6)
Equity withheld for employee taxes	(1,843)			(1,843)
Stock-based compensation expense	24,902			24,902
Exercise of stock options (in shares)		147
Exercise of stock options	6,410			6,410
Issuance of common stock from employee stock purchase plan (in shares)		55
Issuance of common stock from employee stock purchase plan	12,384			12,384
Other comprehensive income (loss)	9,793						9,793
Net income	18,604				18,604
Balance, end of period (in shares) at Jun. 30, 2022		57,353
Balance, end of period at Jun. 30, 2022	2,624,006	$ 57		760,975	1,937,855	$ (177)	(76,357)	1,653
Treasury stock, end of period (in shares) at Jun. 30, 2022						20
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)			8
Equity withheld for employee taxes (in shares)		(2)
Equity withheld for employee taxes	(837)			(837)
Stock issued in connection with Other 2021 acquisitions (Note 3) (in shares)		6				(6)
Stock issued in connection with Other 2021 acquisitions	2,000			1,941		$ 59
Stock-based compensation expense	30,597			30,597
Exercise of stock options (in shares)		137
Exercise of stock options	9,223			9,223
Purchase of subsidiary shares from noncontrolling interest	(197)			51				(248)
Contributions to consolidated subsidiary from noncontrolling interest	73							73
Other comprehensive income (loss)	(62,275)						(62,275)
Net income	156,054				156,054
Balance, end of period (in shares) at Sep. 30, 2022		57,502
Balance, end of period at Sep. 30, 2022	$ 2,758,644	$ 57		801,950	2,093,909	$ (118)	(138,632)	1,478
Treasury stock, end of period (in shares) at Sep. 30, 2022						14
Balance, beginning of period (in shares) at Dec. 31, 2022	57,655	57,655
Balance, beginning of period at Dec. 31, 2022	$ 3,003,010	$ 58		847,965	2,248,948	$ (118)	(95,321)	1,478
Treasury stock, beginning of period (in shares) at Dec. 31, 2022						14
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)			224
Equity withheld for employee taxes (in shares)		(72)
Equity withheld for employee taxes	(20,501)			(20,501)
Stock-based compensation expense	34,265			34,265
Exercise of stock options (in shares)		71
Exercise of stock options	2,525			2,525
Repurchase of common stock (in shares)		(30)
Repurchase of common stock	(8,510)				(8,510)
Other comprehensive income (loss)	17,361						17,361
Net income	102,292				102,292
Balance, end of period (in shares) at Mar. 31, 2023		57,848
Balance, end of period at Mar. 31, 2023	$ 3,130,442	$ 58		864,254	2,342,730	$ (118)	(77,960)	1,478
Treasury stock, end of period (in shares) at Mar. 31, 2023						14
Balance, beginning of period (in shares) at Dec. 31, 2022	57,655	57,655
Balance, beginning of period at Dec. 31, 2022	$ 3,003,010	$ 58		847,965	2,248,948	$ (118)	(95,321)	1,478
Treasury stock, beginning of period (in shares) at Dec. 31, 2022						14
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	292
Other comprehensive income (loss)	$ 3,691
Net income	$ 319,529
Balance, end of period (in shares) at Sep. 30, 2023	57,693	57,693
Balance, end of period at Sep. 30, 2023	$ 3,300,018	$ 58		951,086	2,440,043	$ (118)	(91,630)	579
Treasury stock, end of period (in shares) at Sep. 30, 2023						14
Balance, beginning of period (in shares) at Mar. 31, 2023		57,848
Balance, beginning of period at Mar. 31, 2023	3,130,442	$ 58		864,254	2,342,730	$ (118)	(77,960)	1,478
Treasury stock, beginning of period (in shares) at Mar. 31, 2023						14
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)			76
Equity withheld for employee taxes (in shares)		(21)
Equity withheld for employee taxes	(6,142)			(6,142)
Stock-based compensation expense	32,449			32,449
Exercise of stock options (in shares)		170
Exercise of stock options	4,601			4,601
Issuance of common stock from employee stock purchase plan (in shares)		77
Issuance of common stock from employee stock purchase plan	18,466			18,466
Repurchase of common stock (in shares)		(195)
Repurchase of common stock	(41,437)				(41,437)
Purchase of subsidiary shares from noncontrolling interest	(1,453)			(48)				(1,405)
Contributions to consolidated subsidiary from noncontrolling interest	506							506
Other comprehensive income (loss)	5,875						5,875
Net income	120,033				120,033
Balance, end of period (in shares) at Jun. 30, 2023		57,955
Balance, end of period at Jun. 30, 2023	3,263,340	$ 58		913,580	2,421,326	$ (118)	(72,085)	579
Treasury stock, end of period (in shares) at Jun. 30, 2023						14
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)			7
Equity withheld for employee taxes (in shares)		(2)
Equity withheld for employee taxes	(426)			(426)
Stock-based compensation expense	34,949			34,949
Exercise of stock options (in shares)		51
Exercise of stock options	2,983			2,983
Repurchase of common stock (in shares)		(318)
Repurchase of common stock	(78,487)				(78,487)
Other comprehensive income (loss)	(19,545)						(19,545)
Net income	$ 97,204				97,204
Balance, end of period (in shares) at Sep. 30, 2023	57,693	57,693
Balance, end of period at Sep. 30, 2023	$ 3,300,018	$ 58		$ 951,086	$ 2,440,043	$ (118)	$ (91,630)	$ 579
Treasury stock, end of period (in shares) at Sep. 30, 2023						14